Human macrophages limit oxidation products in low density lipoprotein

<p>Abstract</p> <p>This study tested the hypothesis that human macrophages have the ability to modify oxidation products in LDL and oxidized LDL (oxLDL) via a cellular antioxidant defence system. While many studies have focused on macrophage LDL oxidation in atherosclerosis develop...

Full description

Bibliographic Details
Main Authors: Dahlgren Claes, Marklund Stefan L, van Reyk David, Krettek Alexandra, Ullström Christina, Hultén Lillemor, Wiklund Olov
Format: Article
Language:English
Published: BMC 2005-03-01
Series:Lipids in Health and Disease
Subjects:
LDL
Online Access:http://www.lipidworld.com/content/4/1/6
id doaj-5e05136e877d4fcd8d9fc9bbbad84915
record_format Article
spelling doaj-5e05136e877d4fcd8d9fc9bbbad849152020-11-24T23:57:14ZengBMCLipids in Health and Disease1476-511X2005-03-0141610.1186/1476-511X-4-6Human macrophages limit oxidation products in low density lipoproteinDahlgren ClaesMarklund Stefan Lvan Reyk DavidKrettek AlexandraUllström ChristinaHultén LillemorWiklund Olov<p>Abstract</p> <p>This study tested the hypothesis that human macrophages have the ability to modify oxidation products in LDL and oxidized LDL (oxLDL) via a cellular antioxidant defence system. While many studies have focused on macrophage LDL oxidation in atherosclerosis development, less attention has been given to the cellular antioxidant capacity of these cells.</p> <p>Compared to cell-free controls (6.2 ± 0.7 nmol/mg LDL), macrophages reduced TBARS to 4.42 ± 0.4 nmol/mg LDL after 24 h incubation with LDL (P = 0.022). After 2 h incubation with oxLDL, TBARS were 3.69 ± 0.5 nmol/mg LDL in cell-free media, and 2.48 ± 0.9 nmol/mg LDL in the presence of macrophages (P = 0.034). A reduction of lipid peroxides in LDL (33.7 ± 6.6 nmol/mg LDL) was found in the presence of cells after 24 h compared to cell-free incubation (105.0 ± 14.1 nmol/mg LDL) (P = 0.005). The levels of lipid peroxides in oxLDL were 137.9 ± 59.9 nmol/mg LDL and in cell-free media 242 ± 60.0 nmol/mg LDL (P = 0.012). Similar results were obtained for hydrogen peroxide. Reactive oxygen species were detected in LDL, acetylated LDL, and oxLDL by isoluminol-enhanced chemiluminescence (CL). Interestingly, oxLDL alone gives a high CL signal. Macrophages reduced the CL response in oxLDL by 45% (P = 0.0016). The increased levels of glutathione in oxLDL-treated macrophages were accompanied by enhanced catalase and glutathione peroxidase activities.</p> <p>Our results suggest that macrophages respond to oxidative stress by endogenous antioxidant activity, which is sufficient to decrease reactive oxygen species both in LDL and oxLDL. This may suggest that the antioxidant activity is insufficient during atherosclerosis development. Thus, macrophages may play a dual role in atherogenesis, i.e. both by promoting and limiting LDL-oxidation.</p> http://www.lipidworld.com/content/4/1/6MacrophagesLDLlipid peroxidesantioxidant enzymes
collection DOAJ
language English
format Article
sources DOAJ
author Dahlgren Claes
Marklund Stefan L
van Reyk David
Krettek Alexandra
Ullström Christina
Hultén Lillemor
Wiklund Olov
spellingShingle Dahlgren Claes
Marklund Stefan L
van Reyk David
Krettek Alexandra
Ullström Christina
Hultén Lillemor
Wiklund Olov
Human macrophages limit oxidation products in low density lipoprotein
Lipids in Health and Disease
Macrophages
LDL
lipid peroxides
antioxidant enzymes
author_facet Dahlgren Claes
Marklund Stefan L
van Reyk David
Krettek Alexandra
Ullström Christina
Hultén Lillemor
Wiklund Olov
author_sort Dahlgren Claes
title Human macrophages limit oxidation products in low density lipoprotein
title_short Human macrophages limit oxidation products in low density lipoprotein
title_full Human macrophages limit oxidation products in low density lipoprotein
title_fullStr Human macrophages limit oxidation products in low density lipoprotein
title_full_unstemmed Human macrophages limit oxidation products in low density lipoprotein
title_sort human macrophages limit oxidation products in low density lipoprotein
publisher BMC
series Lipids in Health and Disease
issn 1476-511X
publishDate 2005-03-01
description <p>Abstract</p> <p>This study tested the hypothesis that human macrophages have the ability to modify oxidation products in LDL and oxidized LDL (oxLDL) via a cellular antioxidant defence system. While many studies have focused on macrophage LDL oxidation in atherosclerosis development, less attention has been given to the cellular antioxidant capacity of these cells.</p> <p>Compared to cell-free controls (6.2 ± 0.7 nmol/mg LDL), macrophages reduced TBARS to 4.42 ± 0.4 nmol/mg LDL after 24 h incubation with LDL (P = 0.022). After 2 h incubation with oxLDL, TBARS were 3.69 ± 0.5 nmol/mg LDL in cell-free media, and 2.48 ± 0.9 nmol/mg LDL in the presence of macrophages (P = 0.034). A reduction of lipid peroxides in LDL (33.7 ± 6.6 nmol/mg LDL) was found in the presence of cells after 24 h compared to cell-free incubation (105.0 ± 14.1 nmol/mg LDL) (P = 0.005). The levels of lipid peroxides in oxLDL were 137.9 ± 59.9 nmol/mg LDL and in cell-free media 242 ± 60.0 nmol/mg LDL (P = 0.012). Similar results were obtained for hydrogen peroxide. Reactive oxygen species were detected in LDL, acetylated LDL, and oxLDL by isoluminol-enhanced chemiluminescence (CL). Interestingly, oxLDL alone gives a high CL signal. Macrophages reduced the CL response in oxLDL by 45% (P = 0.0016). The increased levels of glutathione in oxLDL-treated macrophages were accompanied by enhanced catalase and glutathione peroxidase activities.</p> <p>Our results suggest that macrophages respond to oxidative stress by endogenous antioxidant activity, which is sufficient to decrease reactive oxygen species both in LDL and oxLDL. This may suggest that the antioxidant activity is insufficient during atherosclerosis development. Thus, macrophages may play a dual role in atherogenesis, i.e. both by promoting and limiting LDL-oxidation.</p>
topic Macrophages
LDL
lipid peroxides
antioxidant enzymes
url http://www.lipidworld.com/content/4/1/6
work_keys_str_mv AT dahlgrenclaes humanmacrophageslimitoxidationproductsinlowdensitylipoprotein
AT marklundstefanl humanmacrophageslimitoxidationproductsinlowdensitylipoprotein
AT vanreykdavid humanmacrophageslimitoxidationproductsinlowdensitylipoprotein
AT krettekalexandra humanmacrophageslimitoxidationproductsinlowdensitylipoprotein
AT ullstromchristina humanmacrophageslimitoxidationproductsinlowdensitylipoprotein
AT hultenlillemor humanmacrophageslimitoxidationproductsinlowdensitylipoprotein
AT wiklundolov humanmacrophageslimitoxidationproductsinlowdensitylipoprotein
_version_ 1725454972864167936